Kinase inhibition with BAY 43-9006 in renal cell carcinoma.
Ahmad
Tanya
T
Royal Marsden Hospital, London and Surrey, United Kingdom.
Eisen
Tim
T
D001557:Benzenesulfonates / Q000627:therapeutic use* / Q000633:toxicity*; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use* / Q000633:toxicity*; D000077157:Sorafenib; D014057:Tomography, X-Ray Computed
D001557:Benzenesulfonates; D004791:Enzyme Inhibitors; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib